Gas Station
Opioids

Kratom, 7-OH, tianeptine and emerging opioid-active compounds. Recognize the names, understand the evidence, and know what to do in an emergency.

See the SubstancesProtect Your Family

An opioid-active product does not need to look like a prescription drug.

Shots, tablets, capsules and powders may be marketed with botanical imagery or unfamiliar chemical names. Some contain kratom alkaloids or concentrated derivatives; others contain unrelated drugs such as tianeptine. Their risks, evidence and legal status are not identical. A product's label alone cannot establish its contents.

Substances you must recognize

Select an existing guide where available. New entries identify compounds worth watching without claiming that every one has been confirmed in ordinary gas-station retail sales.

KRATOMMitragynine and concentrated extractsRetail productsKratom leaf contains mitragynine, an alkaloid with opioid-receptor activity. Extracts can deliver substantially different exposures than plain leaf.Read existing guide → 7-OH7-HydroxymitragynineCommercial products documentedAn opioid-active kratom alkaloid sold in concentrated tablets, shots and other formulations. Product strength and labeling vary.Read existing guide → PSEUDOINDOXYLMitragynine pseudoindoxyl (MP)Reported in products / laboratory testingPotent opioid-active compound related to mitragynine. A label may not disclose its presence; laboratory identification matters.Read existing guide → MGM-15Mitragynine analogEmerging analog / verify retail claimsResearch describes opioid-receptor activity. Do not assume widespread retail distribution without product-specific documentation.Read existing guide → TIANEPTINEOften called “gas station heroin”Commercial products documentedAn antidepressant in some countries that also acts at mu-opioid receptors. U.S. retail products have been linked to poisonings, dependence and withdrawal.Read existing guide → SR-17018Experimental mu-opioid receptor agonistResearch chemical / reported onlineExperimental compound with limited human safety data. It is not an approved medicine; online marketing does not establish quality or safety.Read existing guide → AKUAMMAPicralima nitida seed productsBotanical / different evidence baseContains alkaloids studied for pharmacologic effects. Evidence does not justify treating it as equivalent to concentrated kratom opioids.Read existing guide → CORYDALISCorydalis botanical productsBotanical / different evidence baseContains bioactive alkaloids, but should not be presented as a proven mu-opioid equivalent to 7-OH.Read existing guide →
7-OH

Concentrated commercial products are documented. A naturally occurring trace alkaloid is not the same exposure as a high-dose retail formulation.

MP

Mitragynine pseudoindoxyl requires compound-specific identification; packaging may not disclose it.

Evidence

Laboratory opioid activity does not prove human safety, clinical potency or commercial availability.

What parents should look for

Product and packaging clues

  • Names such as 7-OH, 7-hydroxy, pseudoindoxyl, MP, mitragynine or tianeptine
  • Small shots, chewable tablets, gummies, capsules and concentrated powders
  • Claims such as “extra strength,” “research use only” or “not for human consumption”
  • Ingredient lists without clear amounts or third-party analytical results
  • Brand names and formulas that change faster than laws and testing programs

Possible signs of opioid toxicity

  • Unusual sleepiness or inability to wake the person
  • Slow, irregular or absent breathing
  • Gurgling, choking or snoring sounds with unresponsiveness
  • Blue or gray lips, especially with impaired breathing
  • Pinpoint pupils can occur, but their absence does not rule out overdose

Recognize an emergency and take action

If someone is unresponsive or breathing abnormally, call 911 immediately. Give naloxone if available and follow the device instructions; additional doses may be needed. Start CPR or rescue breathing as directed by the dispatcher, and stay with the person. Naloxone may reverse opioid effects but will not reverse every ingredient in a mixed product.

After a suspected exposure

  • For poisoning advice in the U.S., call Poison Control at 1-800-222-1222.
  • Keep the packaging or photograph the ingredients for clinicians.
  • Do not make the person vomit or leave an unconscious person alone.
  • Seek clinical help for dependence or withdrawal; stopping suddenly may require medical support.

Report and document

  • Record the product name, lot number, purchase location and date.
  • Report suspected adverse events through FDA MedWatch.
  • Use the site's existing reporting and parent resources.
  • Distinguish verified laboratory findings from advertising claims.
Report a ProductGet Help

Sources and evidence standards

This page separates documented retail products from emerging compounds. It does not assume that every opioid-active substance is widely sold, or that receptor potency predicts human overdose risk.

Updated October 2026. Product availability, scheduling and laboratory findings change. The presence of an entry here is not proof that a particular product is currently legal or commercially available.